Literature DB >> 10826897

Screening and diagnosis of congenital cytomegalovirus infection: a 5-y study.

G Halwachs-Baumann1, B Genser, M Danda, H Engele, H Rosegger, B Fölsch, U Maurer, H Lackner, M Truschnig-Wilders.   

Abstract

Although cytomegalovirus infection is the most common infection transmitted via the placenta, there are no guidelines for routine screening to detect children congenitally infected with cytomegalovirus. From 1993 to 1997, maternal serum and cord vein blood of newborns was screened for HCMV-IgM (n = 21,183). Urine was examined for HCMV-excretion during the first postnatal week to prove HCMV infection in children who expressed HCMV-IgM in cord vein blood (n = 13) or who were born to mothers positive for HCMV-IgM in the serum (n = 234), or when both cord vein blood and maternal serum were positive for HCMV-IgM (n = 6). Congenital HCMV infection was detected in 17 newborns. To determine the incidence of congenital HCMV infection, only those mother/child pairs were selected in whom serum and cord vein blood were investigated (n = 5967 mother/child pairs). In this group 13 newborns were infected. The observed incidence for congenital HCMV infection is 0.21%. It is concluded that that this screening programme will detect those children at risk for congenital HCMV infection. These children have to be examined for virus excretion in the urine. Although the observed incidence is only 0.21%, congenital HCMV infection is a problem that can no longer be neglected because of its long-term sequelae.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10826897     DOI: 10.1080/003655400750045222

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  8 in total

Review 1.  Safety of alternative antiviral agents for neonatal herpes simplex virus encephalitis and disseminated infection.

Authors:  Yu Wang; Katherine P Smith
Journal:  J Pediatr Pharmacol Ther       Date:  2014-04

Review 2.  Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries.

Authors:  Tatiana M Lanzieri; Sheila C Dollard; Stephanie R Bialek; Scott D Grosse
Journal:  Int J Infect Dis       Date:  2014-03-12       Impact factor: 3.623

3.  Congenital cytomegalovirus infection in high-risk Canadian infants: Report of a pilot screening study.

Authors:  Wendy Vaudry; Rhonda J Rosychuk; Bonita E Lee; Po Yin Cheung; Xl Pang; Jutta K Preiksaitis
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

4.  Overview of the diagnosis of cytomegalovirus infection.

Authors:  S A Ross; Z Novak; S Pati; S B Boppana
Journal:  Infect Disord Drug Targets       Date:  2011-10

5.  Broad-spectrum antiherpes activities of 4-hydroxyquinoline carboxamides, a novel class of herpesvirus polymerase inhibitors.

Authors:  Nancee L Oien; Roger J Brideau; Todd A Hopkins; Janet L Wieber; Mary L Knechtel; John A Shelly; Robert A Anstadt; Peter A Wells; Roger A Poorman; Audris Huang; Vallerie A Vaillancourt; Terrance L Clayton; John A Tucker; Michael W Wathen
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

6.  Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population.

Authors:  Marisa M Mussi-Pinhata; Aparecida Y Yamamoto; Rosângela M Moura Brito; Myriam de Lima Isaac; Patricia F de Carvalho e Oliveira; Suresh Boppana; William J Britt
Journal:  Clin Infect Dis       Date:  2009-08-15       Impact factor: 9.079

7.  Prevalence of CMV infection among staff in a metropolitan children's hospital - occupational health screening findings.

Authors:  Johanna Stranzinger; Jutta Kindel; Melanie Henning; Dana Wendeler; Albert Nienhaus
Journal:  GMS Hyg Infect Control       Date:  2016-09-27

8.  Congenital Cytomegalovirus Infection Burden and Epidemiologic Risk Factors in Countries With Universal Screening: A Systematic Review and Meta-analysis.

Authors:  Paddy Ssentongo; Christine Hehnly; Patricia Birungi; Mikayla A Roach; Jada Spady; Claudio Fronterre; Ming Wang; Laura E Murray-Kolb; Laila Al-Shaar; Vernon M Chinchilli; James R Broach; Jessica E Ericson; Steven J Schiff
Journal:  JAMA Netw Open       Date:  2021-08-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.